Molecular dissection of a medicinal herb with anti-tumor activity by oligonucleotide microarray

Life Sciences

Volumn 77, Issue 9, 2005, Pages 991-1002

  Hara, Akiko ^a   Iizuka, Norio ^a   Hamamoto, Yoshihiko ^b   Uchimura, Shunji ^b   Miyamoto, Takanobu ^b   Tsunedomi, Ryouichi ^a   Miyamoto, Koji ^a   Hazama, Shoichi ^a   Okita, Kiwamu ^a   Oka, Masaaki ^a  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b YAMAGUCHI UNIVERSITY   (Japan)

Author keywords

Berberine; Coptidis rhizoma; Herb; Microarray; Pancreatic cancer

Indexed keywords

ALKALOID DERIVATIVE; BERBERINE; BEROLINE; CANADINE; COLUMBAMINE; COPTIS RHIZOME; COPTISINE; EPIBERBERINE; GROENLANDICINE; PALMATINE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CLUSTER ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; DNA MICROARRAY; GENE EXPRESSION; GENE IDENTIFICATION; HERB; HUMAN; HUMAN CELL; MOLECULE; NUCLEOTIDE SEQUENCE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BERBERINE ALKALOIDS; CELL LINE, TUMOR; COPTIS; DRUGS, CHINESE HERBAL; GENE EXPRESSION PROFILING; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PANCREATIC NEOPLASMS;

COPTIDIS RHIZOMA;

EID: 20444455383     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2005.01.018     Document Type: Article

References (35)

1. M. Bonham, H. Arnold, B. Montgomery, and P.S. Nelson Molecular effects of the herbal compound PC-SPES: identification of activity pathways in prostate carcinoma Cancer Research 62 2002 3920 3924
2. A. Brazma, and J. Vilo Gene expression data analysis FEBS Letters 480 2000 17 24
3. J. DeRisi, L. Penland, P.O. Brown, M.L. Bittner, P.S. Meltzer, M. Ray, Y. Chen, Y.A. Su, and J.M. Trent Use of a cDNA microarray to analyze gene expression patterns in human cancer Nature Genetics 14 1996 457 460
4. R.S. DiPaola, H. Zhang, G.H. Lambert, R. Meeker, E. Licitra, M.M. Rafi, B.T. Zhu, H. Spaulding, S. Goodin, M.B. Toledano, W.N. Hait, and M.A. Gallo Clinical and biologic activity of an estrogenic herbal combination (PC-SPES) in prostate cancer New England Journal of Medicine 339 1998 785 791
5. T. Efferth, A. Sauerbrey, A. Olbrich, E. Gebhart, P. Rauch, H.O. Weber, J.G. Hengstler, M.E. Halatsch, M. Volm, K.D. Tew, D.D. Ross, and J.O. Funk Molecular modes of action of artesunate in tumor cell lines Molecular Pharmacology 64 2003 382 394
6. M.B. Eisen, P.T. Spellman, P.O. Brown, and D. Botstein Cluster analysis and display of genome-wide expression patterns Proceedings of National Academy of Science U S A 95 1998 14863 14868
7. D.M. Eisenberg, R.C. Kessler, C. Foster, F.E. Norlock, D.R. Calkins, and T.L. Delbanco Unconventional medicine in the United States. Prevalence, costs, and patterns of use New England Journal of Medicine 328 1993 246 252
8. A. Fugh-Berman Herb-drug interactions Lancet 355 2000 134 138
9. T.R. Golub, D.K. Slonim, P. Tamayo, C. Huard, M. Gaasenbeek, J.P. Mesirov, H. Coller, M.L. Loh, J.R. Downing, M.A. Caligiuri, C.D. Bloomfield, and E.S. Lander Molecular classification of cancer: class discovery and class prediction by gene expression monitoring Science 286 1999 531 537
10. D.P. Hartley, X. Dai, Y.D. He, E.J. Carlini, B. Wang, S.E. Huskey, R.G. Ulrich, T.H. Rushmore, R. Evers, and D.C. Evans Activators of the rat pregnane X receptor differentially modulate hepatic and intestinal gene expression Molecular Pharmacology 65 2004 1159 1171
11. H.S. Ho, and C.F. Frey Current approach to the surgical management of chronic pancreatitis Gastroenterologist 5 1997 128 136
12. N. Iizuka, K. Hirose, T. Noma, S. Hazama, A. Tangoku, H. Hayashi, T. Abe, K. Yamamoto, and M. Oka The nm23-H1 gene as a predictor of sensitivity to chemotherapeutic agents in oesophageal squamous cell carcinoma British Journal of Cancer 81 1999 469 475
13. N. Iizuka, K. Miyamoto, K. Okita, A. Tangoku, H. Hayashi, S. Yosino, T. Abe, T. Morioka, S. Hazama, and M. Oka Inhibitory effect of Coptidis Rhizoma and berberine on the proliferation of human esophageal cancer cell lines Cancer Letters 148 2000 19 25
14. N. Iizuka, M. Oka, H. Yamada-Okabe, N. Mori, T. Tamesa, T. Okada, N. Takemoto, A. Tangoku, K. Hamada, H. Nakayama, T. Miyamoto, S. Uchimura, and Y. Hamamoto Comparison of gene expression profiles between hepatitis B virus-and hepatitis C virus-infected hepatocellular carcinoma by oligonucleotide microarray data on the basis of a supervised learning method Cancer Research 62 2002 3939 3944
15. N. Iizuka, S. Hazama, K. Yoshimura, S. Yoshino, A. Tangoku, K. Miyamoto, K. Okita, and M. Oka Anticachectic effects of the natural herb Coptidis rhizoma and berberine on mice bearing colon 26/clone 20 adenocarcinoma International Journal of Cancer 99 2002 286 291
16. N. Iizuka, M. Oka, K. Yamamoto, A. Tangoku, K. Miyamoto, T. Miyamoto, S. Uchimura, Y. Hamamoto, and K. Okita Identification of common or distinct genes related to antitumor activities of a medicinal herb and its major component by oligonucleotide microarray International Journal of Cancer 107 2003 666 672
17. N. Iizuka, M. Oka, H. Yamada-Okabe, N. Mori, T. Tamesa, T. Okada, N. Takemoto, K. Hashimoto, A. Tangoku, K. Hamada, H. Nakayama, T. Miyamoto, S. Uchimura, and Y. Hamamoto Differential gene expression in distinct virologic types of hepatocellular carcinoma: association with liver cirrhosis Oncogene 22 2003 3007 3014
18. N. Iizuka, M. Oka, H. Yamada-Okabe, M. Nishida, Y. Maeda, N. Mori, T. Takao, T. Tamesa, A. Tangoku, H. Tabuchi, K. Hamada, H. Nakayama, H. Ishitsuka, T. Miyamoto, iA. Hirabayash, S. Uchimura, and Y. Hamamoto Oligonucleotide microarray for prediction of early intrahepatic recurrence of hepatocellular carcinoma after curative resection Lancet 361 2003 923 929
19. N. Iizuka, M. Oka, H. Yamada-Okabe, N. Mori, T. Tamesa, T. Okada, N. Takemoto, K. Sakamoto, K. Hamada, H. Ishitsuka, T. Miyamoto, S. Uchimura, and Y. Hamamoto Self-organizing-map-based molecular signature representing the development of hepatocellular carcinoma FEBS Letters 579 2005 1089 1100
20. H. Kawasaki, G.M. Springett, N. Mochizuki, S. Toki, M. Nakaya, M. Matsuda, D.E. Housman, and A.M. Graybiel A family of cAMP-binding proteins that directly activate Rap1 Science 282 1998 2275 2279
21. J.S. Kim, H. Tanaka, and Y. Shoyama Immunoquantitative analysis for berberine and its related compounds using monoclonal antibodies in herbal medicines Analyst 129 2004 87 91
22. Y. Kobayashi, Y. Yamashita, N. Fujii, K. Takaboshi, T. Kawakami, M. Kawamura, T. Mizukami, and H. Nakano Inhibitors of DNA topoisomerase I and II isolated from the Coptis rhizomes Planta Medica 61 1995 414 418
23. G. Lagna, R. Kovelman, J. Sukegawa, and R.G. Roeder Cloning and characterization of an evolutionarily divergent DNA-binding subunit of mammalian TFIIIC Molecular and Cellular Biology 14 1994 3053 3064
24. X.K. Li, M. Motwani, W. Tong, W. Bornmann, and G.K. Schwartz Huanglian, A chinese herbal extract, inhibits cell growth by suppressing the expression of cyclin B1 and inhibiting CDC2 kinase activity in human cancer cells Molecular Pharmacology 58 2000 1287 1293
25. H.L. Lin, T.Y. Liu, C.W. Wu, and C.W. Chi Berberine modulates expression of mdr1 gene product and the responses of digestive track cancer cells to Paclitaxel British Journal of Cancer 81 1999 416 422
26. K. Linde, G. Ramirez, C.D. Mulrow, A. Pauls, W. Weidenhammer, and D. Melchart St. John's Wort for depression-an overview and meta-analysis of randomised clinical trials British Medical Journal 313 1996 253 258
27. M.J. MacKenzie Molecular therapy in pancreatic adenocarcinoma Lancet Oncology 5 2004 541 549
28. Y. Masuda, A. Nishida, K. Hori, T. Hirabayashi, S. Kajimoto, S. Nakajo, T. Kondo, M. Asaka, and K. Nakaya Beta-hydroxyisovalerylshikonin induces apoptosis in human leukemia cells by inhibiting the activity of a polo-like kinase 1 (PLK1) Oncogene 22 2003 1012 1023
29. T. Okada, N. Iizuka, H. Yamada-Okabe, N. Mori, T. Tamesa, N. Takemoto, A. Tangoku, K. Hamada, H. Nakayama, T. Miyamoto, S. Uchimura, Y. Hamamoto, and M. Oka Gene expression profile linked to p53 status in hepatitis C virus-related hepatocellular carcinoma FEBS Letters 555 2003 583 590
30. L.C. Sanders, F. Matsumura, G.M. Bokoch, and P. de Lanerolle Inhibition of myosin light chain kinase by p21-activated kinase Science 283 1999 2083 2085
31. M.M. Sanders, A.A. Liu, T.K. Li, H.Y. Wu, S.D. Desai, Y. Mao, E.H. Rubin, E.J. LaVoie, D. Makhey, and L.F. Liu Selective cytotoxicity of topoisomerase-directed protoberberines against glioblastoma cells Biochemical Pharmacology 56 1998 1157 1166
32. M. Schena, D. Shalon, R.W. Davis, and P.O. Brown Quantitative monitoring of gene expression patterns with a complementary DNA microarray Science 270 1995 467 470
33. U. Scherf, D.T. Ross, M. Waltham, L.H. Smith, J.K. Lee, L. Tanabe, K.W. Kohn, W.C. Reinhold, T.G. Myers, D.T. Andrews, D.A. Scudiero, M.B. Eisen, E.A. Sausville, Y. Pommier, D. Botstein, P.O. Brown, and J.N. Weinstein A gene expression database for the molecular pharmacology of cancer Nature Genetics 24 2000 236 244
34. F.R. Stermitz, P. Lorenz, J.N. Tawara, L.A. Zenewicz, and K. Lewis Synergy in a medicinal plant: antimicrobial action of berberine potentiated by 5′-methoxyhydnocarpin, a multidrug pump inhibitor Proceedings of National Academy of Science U S A 97 2000 1433 1437
35. M.E. Wall, and M.C. Wani Camptothecin and taxol: discovery to clinic-thirteenth Bruce F. Cain Memorial Award Lecture Cancer Research 55 1995 753 760